BlackRock, Inc. 13D and 13G filings for Inovio Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-07-07 4:35 pm Sale |
2023-06-30 | 13G | Inovio Pharmaceuticals, Inc. INO |
BLACKROCK INC BLK |
507,219 2.300% |
-1,433,125 (-73.86%) |
Filing |
| 2023-01-24 1:56 pm Purchase |
2022-12-31 | 13G | Inovio Pharmaceuticals, Inc. INO |
BLACKROCK INC BLK |
1,940,343 9.300% |
419,934 (+27.62%) |
Filing |
| 2022-02-01 5:08 pm Purchase |
2021-12-31 | 13G | Inovio Pharmaceuticals, Inc. INO |
BLACKROCK INC BLK |
1,520,410 8.700% |
333,498 (+28.10%) |
Filing |
| 2021-01-29 09:57 am Purchase |
2020-12-31 | 13G | Inovio Pharmaceuticals, Inc. INO |
BLACKROCK INC BLK |
1,186,912 8.400% |
550,695 (+86.56%) |
Filing |